Inventory maintenance, a routine undertaking in most businesses, is among the most crucial tasks performed by pharmacists and may have profound repercussions if not handled accurately. In particular, inventory shortages are common discrepancies noted by pharmacy benefit manager (PBM) audits, and those reviews often prompt referrals and regulatory scrutiny beyond the claims audited. That is all the more so in today’s evolving risk landscape, where states are leveraging various enforcement mechanisms to set-off costs associated with fraud, waste and abuse, and the federal government’s intense focus on the abuse of controlled substances has not waivered.
Here is the on-demand replay of our in-depth webinar discussing the regulatory framework and defense strategies for responding to inventory maintenance allegations.
Our presenter, Frier Levitt partner, Anthony Mahajan, formerly worked as an Assistant United States Attorney in the District of New Jersey, where he investigated and prosecuted numerous controlled substance offenses against manufacturers, distributors, pharmacies and health care professionals. Mr. Mahajan currently serves as Chair of Frier Levitt’s White Collar Defense & Government Investigations practice.
Access the on-demand webinar replay “Defending the Inventory Shortfall: More Complex than First Appears” by filling out the form below: